Saturday, 31 October 2026European Markets

ITESOFT Stock Went Down By Over 10% So Far Today

Loading stream...

(vianews) - shares of itesoft (cac 40: ite.pa) dropped by a staggering 10.11% to €3.38 at 14:55 est on tuesday, after four sequential sessions in a row of losses. cac 40 is falling 0.2% to €7,169.89, following the last session's upward trend. this seems, so far, a somewhat bearish trend trading session today.

about itesoft

itesoft s.a., a software company, provides secure capture and process automation solutions in france and internationally. the company's solutions include itesoft capture as a service, a solution for capturing information with digitization and the acceleration of exchanges; itesoft capture as a service for invoices, provides cloud-based invoice data extraction, and automation service based on a single and multi-tenant core technology. it also offers itesoft fraud detection saas, a solution that identifies suspicious documents. in addition, the company provides itesoft freemind, a solution for enterprises to process all document flows in various formats, such as paper, barcode, fax, email, and manuscript; and itesoft freemind for invoices, a solution for capturing and extracting supplier invoices. further, it offers itesoft balance, a solution that handles reconciliation, accounting integration in sap, and oracle certified erp and generic erp modules; and itesoft analytics that supervises entire process invoices from reception to payments. it serves customers in banking, insurance, commerce, industry, public sector, social organizations, etc. itesoft s.a. was incorporated in 1984 and is headquartered in aimargues, france. itesoft s.a. is a subsidiary of cdml sas.

earnings per share

as for profitability, itesoft has a trailing twelve months eps of €-0.23.

volume

today's last reported volume for itesoft is 7646 which is 4864.93% above its average volume of 154.

more news about itesoft (ite.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
ITESOFT Stock Went Down By Over 10% So Far Today | ViaNews EU